658 - Evaluation of Effectiveness of Cefmetazole vs Meropenem for Invasive Urinary Tract Infections Caused by ESBL-Producing Escherichia coli: A Prospective Multicenter Observational Study

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

KU

Kohei Uemura, PhD

The University of Tokyo
Bunkyo-ku, Tokyo, Japan
YM

Yasufumi Matsumura, PhD, MD

Kyoto University Graduate School of Medicine
Kyoto, Kyoto, Japan
AS

Aki Sakurai, MD

Fujita Health University
Aichi, Aichi, Japan
RT

Ryutaro Tanizaki, MD

Ise Municipal General Hospital
Ise-shi, Mie, Japan
Koh Shinohara, MD

PhD student
Kyoto University Graduate School of Medicine
Kyoto, Kyoto, Japan
TH

Takehiro Hashimoto, MD

Oita University Hospital
Yufu-shi, Oita, Japan
HK

Hideaki Kato, MD, PhD

Senior Lecturer
Yokohama City University Hospital
yokohama-shi, Kanagawa, Japan
TM

Takashi Matono, MD

Iizuka Hospital
Fukuoka, Fukuoka, Japan
RH

Ryota Hase, MD

Chief
Japanese Red Cross Narita Hospital
Narita-shi, Chiba, Japan
MM

Momoko Mawatari, MD

Japanese Red Cross Medical Center
Tokyo, Tokyo, Japan
HH

Hiroshi Hara, Pharmacist

Yokohama Municipal Stroke and Neurospine Center
Kanagawa, Kanagawa, Japan
YH

Yukihiro Hamada, Pharm D

Associate Director
Tokyo Women's Medical University
Tokyo, Tokyo, Japan
Sho Saito, MD, PhD

Disease Control and Prevention Center
National Center for Global Health and Medicine
Shinjuku-ku, Tokyo, Japan
YD

Yohei Doi, MD, PhD

Fujita Health University
Aichi, Aichi, Japan